Top Markets
Coin of the day
Cardax, Inc. Cardax, Inc.

Cardax, Inc.

CDXI
Clasificación en acciones #42795
Cardax, Inc. is a biopharmaceutical enterprise focused on both creating and... Cardax, Inc. is a biopharmaceutical enterprise focused on both creating and marketing nutritional supplements for maintaining inflammatory well-being, as well as developing pharmaceutical treatments for chronic ailments rooted in inflammation and oxidative stress. Its product portfolio includes ZanthoSyn, an advanced supplement for inflammation, health, and longevity that delivers astaxanthin with superior absorption and purity. This product is primarily distributed through online sales and wholesale channels. The company is also progressing two pharmaceutical candidates: CDX-101, an astaxanthin-derived drug candidate intended to address cardiovascular inflammation and dyslipidemia, with a primary focus on severe hypertriglyceridemia; and CDX-301, a zeaxanthin-based pharmaceutical currently under development for macular degeneration. Cardax, Inc. maintains its headquarters in Honolulu, Hawaii.
Precio por acción
$0.0001
Última sincronización: 2026-08-11
Capitalización bursátil
$80.00
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Cardax, Inc. (CDXI)

Categoría

Historial del precio de la acción de Cardax, Inc. (CDXI)
Precio más alto de cierre: $0.00 el 2026-08-01

Precio más bajo de cierre: $30.00 el 2013-03-01
Historial del precio de la acción de Cardax, Inc. desde 2013 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 0.00%
2025 4.48%
2024 -91.30%
2023 196.15%
2022 -99.95%
2021 -55.81%
2020 -84.57%
2019 -71.42%
2018 4.39%
2017 84.68%
2016 -60.73%
2015 -35.26%
2014 157.83%
2013 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$527.87 36.13%
US
$873.57 37.02%
NL
$736.38 8.73%
CH
$263.09 20.45%
BE
$1.07K -5.56%
KR